Gottlieb: Window for Containing Monkeypox ‘Probably Has Closed’: This is Alarming


Former Food and Drug Administration (FDA) Commissioner Dr. Scott Gottlieb said Sunday on CBS’s “Face the Nation” that the window to control the spread of the monkeypox virus in the United States may be closed.

Partial transcript as follows:

MARGARET: Give us a sense of the scale of this because the CDC numbers are out. They say they’re only eight women within that. No children. You’re saying this is a pandemic? That’s not a word the administration is using yet, what level of emergency are we at?

GOTTLIEB: Yeah look, and I think they’re going to be reluctant to use the word pandemic, because it implies that they’ve failed to contain this. And I think at this point, we’ve failed to contain this. We’re now at the cusp of this becoming an endemic virus where this now becomes something that’s persistent that we need to continue to deal with. I think the window for getting control of this and containing it probably has closed, and if it hasn’t closed, it’s certainly starting to close. 11,000 cases across the world right now. 1,800 cases, as you said, in the US. We’re probably detecting just a fraction of the actual cases because we have a very, we had for a long time a very narrow case definition on who got tested. And by and large, we’re looking in the community of men who have sex with men and STD clinics. So we’re looking there, we’re finding cases there. But it’s a fact that there’s cases outside that community right now. We’re not picking them up, because we’re not looking there. This has spread more broadly in the community. I wouldn’t be surprised there’s thousands of cases right now.

BRENNAN: It’s a little chilling to hear you say containment has failed. I’ve heard you say that before with COVID.

GOTTLIEB: Well look, this isn’t going to explode like COVID. This is a slower moving virus, which is why we could have gotten control of this if we had been more aggressive up front, and we made a lot of the same mistakes that we made with COVID with this – having a very narrow case definition not having enough testing early enough, not deploying vaccine in an aggressive fact- fashion to ring vaccinate. But now this is firmly embedded in the community. And while it’s not going to explode, because it’s harder for this virus to spread, it’s probably going to be persistent, you’ll-you’ll have this as a sort of a fact of life, maybe spreading as a sexually transmitted disease, but also breaking out of those settings.

BRENNAN: So the CDC said monkey pox can show up up to three weeks post exposure. What are the basic symptoms? If you have a rash you call your dermatologist? Who do you call?

GOTTLIEB: Well, it’s a vesicular rash. It’s associated with fever and achiness. You know, the historically used to get a disseminated rash. What we’re seeing right now is people aren’t presenting with a widely diffused rash, but sometimes just a small number of vesicles. So I think it’s being confused with other vesicular rashes, Herpes, Coxsackie could cause a vesicular rash, certainly chickenpox. Right now, anyone who presents with a particular rash that can’t be explained by another etiology. So a rash that causes vesicles, should be tested for monkey pox, whether they come from a high risk community or not. That’s the way we’re going to snuff this out. We didn’t have enough testing to do that. Now CDC has gotten in place more testing this probably adequate testing to broaden it to-to accomplish that. So we should be doing that physicians should be sending off these tests.

BRENNAN: The problem with testing also, it seems that distribution or access to a vaccine is an issue, the mayor of New York, the governor of New York, asking the Biden administration to do more to get them access. Why is this a problem?

GOTTLIEB: Well, we didn’t have adequate stockpiles of the vaccine, the one vaccine that’s proven monkeypox, we only had 2,000 doses in a national strategic stockpile. It was there as a hedge against smallpox, we took our eye off that ball, so we didn’t replenish that supply. They ordered about 300,000 doses that have been delivered. 150,000 have been distributed, another 130,000 will go out this week.

BRENNAN: Some of that overseas.

GOTTLIEB: Some of it- well, there’s 800,000 doses that were overseas, that the manufacturer, Bavarian Nordic, had overseas. Those are being brought into the US right now. FDA has to do what’s called “lot release”, they have to inspect those doses to make sure they were appropriately manufactured. They’re doing that inspection at the same time that they’re forward deploying those 800,000 doses. So those are going to cities right now. And as soon as FDA finishes that, which should be this week, those doses will be turned on, they’ll be able to be distributed or be used on patients. So I think the vaccine situation is going to improve dramatically this week, you’re going to see literally hundreds of thousands of doses become available. The White House has intervened to take more control of the response away from CDC. This can’t be our response every time that when CDC drops the ball, the White House and the political leadership need to step in. That’s what’s happened here. It happened in COVID. We need to fundamentally reform how we respond to these-these crises.

BRENNAN: You wrote a book on that. I want to ask you about COVID. The CDC says now about 54% of Americans live in an area of high COVID Community spread. That’s up from 31%, the prior week, that seems fast moving. What is different about these variants now?

GOTTLIEB: Well, look, it’s the B-5 variant that’s growing. It has the capacity to evade the immunity that we’ve acquired from vaccination and also from prior infection. It does seem to be that B-2 infection confers more robust immunity against this B-5 variants, so places that had big outbreaks of B-2, like the Northeast, are probably going to be more protected. There’s 100,000, over 100,000 cases on average being reported on a daily basis. We’re probably detecting one in 10 infections right now. So it’s probably more like a million. I think most Americans have started to accept this as part of the fabric of daily living. In part that’s, that’s based on a wholesale recalibration of risk, in part is based on the fact that there’s very few people who are immune. I.e so people feel rightly, more impervious to a bad outcome. So we have to recognize that this spread is happening against the backdrop basically, of normal living.

BRENNAN: But the White House is saying put a mask on if you go into indoor gatherings, the city of Los Angeles says they might institute this at the end of the month.

GOTTLIEB: I don’t think we’re going to see mandates. I don’t think there’s a lot of tolerance for mandates, maybe in select cities, like Los Angeles.

BRENNAN: But is it advisable?

GOTTLIEB:  I think if you’re going into a congregate setting with a lot of people you don’t know, wearing a mask is prudent if you’re in a high prevalence area, especially if you’re someone who-who’s at risk. You know, I still wear a mask in certain settings, I wear when I go through the airport. If I catch COVID I want it to be from a family member or friend not some stranger I’m sitting next to on a plane. So I try to be prudent when I’m in mixed company. I think right now, if you live in a high prevalence region, it’s advisable, especially if you’re someone who’s vulnerable if it’s easy enough.

BRENNAN: And a booster shot. Will we have a rebooted bivalent vaccine in the fall?

GOTTLIEB: Yeah,well, look, there’s going to be a vaccine based on B-4 that the manufacturers are developing right now. There is a bivalent vaccine based on B-1 on the shelf right now that we could be deploying, we’re not. That probably would be more protected against this B-4 variant and B-5 variant. We- they’ve made a decision so far not to deploy that but to wait for the B-4 variant vaccine that’s going to be available this fall. Right now, if you’re above the age of 50 and you haven’t had a dose of vaccine this year, you probably should get one, and as sequencing is good, get a dose now if you’re someone who’s at high risk and come back and get one later. SOURCE

PRAY brethren……..PRAY!!

And DON’T get Jabbed!

NYC reveals that 95% of monkeypox patients in the Big Apple are men with ZERO women having been infected so far – and at least 60% are ‘LGBQ’: US case tally reaches 1,470


  • Nearly every single case of monkeypox detected in New York City has been in a man
  • Not a single confirmed case has been in a woman, though there are few cases where the gender is unknown
  • Nearly 60% of cases have been confirmed in someone that reported being gay, biseual or lesbian and no cases are confirmed in a straight person
  • The CDC has been widely panned for failing to provide adequate testing and vaccine supply to deal with the outbreak

Monkeypox infections in New York City are overwhelmingly being found in men – with more than half of cases being detected among lesbian, gay, bisexual or queer people as well.

Officials in the Big Apple revealed the first snapshot of the demographics of people that have been infected with the tropical virus.

Of the 336 cases in the city – the most of any singular locality in America – 321 are among men, with no confirmed cases among women. The remaining five percent of cases are split between transgender persons and cases where the gender is unknown. 

Transgender people were not included with the LGBQ community in the data. 

The virus has famously erupted among communities of gay and bisexual men across the world in recent months after first being detected in Europe, and this data confirms that the community is being hammered by the virus in New York as well.

In total, over 11,000 cases have been detected in nations where the virus is not endemic as part of this outbreak – including 1,470 in the U.S.

According to data from NYC Health, every single person with a confirmed infection in the city is between the ages of 20 and 69, with a median age of 35.

The virus has overwhelmingly hurt males in the city. Nearly every case has been confirmed in a male – which would make sense considering the sexual networks where the virus has so far traveled.

While no cases have been confirmed among women yet, there are still eight cases where the gender of the person was not recorded.

Straight people have largely avoided the virus as well, with only two confirmed cases among the group.

Around 60 percent of confirmed cases are in the LGBQ community. Transgender individuals were not included with this group.

The sexuality of the infected person was unknown in 40 percent of cases.

Monkeypox has spread across racial groups, though. Around one-in-three cases are among white people, with one-in-five found in the Hispanic community.

These figures are likely significant undercounts, though, as officials at the Centers for Disease Control and Prevention have been panned for failing to control the virus.

Monkeypox has been allowed to spread undetected because of failures in America’s testing and surveillance infrastructure – similar to how Covid was allowed to spread so widely early on when it caught the world off guard in early 2020.

Unlike Covid, though, monkeypox is not novel, leaving experts frustrated with how top officials failed to deal with a threat they were already knowledgeable to. 

‘Why is it so hard for something that’s even a known pathogen?’ Dr Anne Rimoin, an epidemiologist at UCLA said to the New York Times.

‘How many more times do we have to go through this?’

America’s monkeypox response has been marred by a fractured and limited testing system and limited access to vaccines that could help Americans get ahead of infection.

Appointments for the monkeypox vaccine in NYC are fully booked MINUTES after opening 

Dozens of people lined up for vaccines against monkeypox in New York City Friday as the city launched its second jabbing drive.

The queue — formed mostly of men — snaked around the side of the Chelsea sexual health clinic in Manhattan this morning.

Gay or bisexual men who have multiple sexual partners over two weeks are again being offered the jab in America’s monkeypox capital, alongside anyone exposed to a patient with the tropical disease.

But the 2,500 appointments available for the jabs ran out within minutes yesterday, as thousands hurried to grab a slot.

Health officials were slammed for a ‘technical glitch’ which allowed so many people to book slots early using an old link that by the time the first batch was released it was already full, leaving frustrated New Yorkers saying they were left with ‘zero chance’ of getting a jab.

At a press briefing last week the city’s health commissioner Dr Ashwin Vasan said the locations had been chosen because three-quarters of cases were in Manhattan. 

This included about a third in the Chelsea and Hell’s Kitchen neighborhoods specifically.

The Health Department is primarily using Twitter to tell people when jabs are available, leaving those who are not regularly on the application in the lurch.

On Wednesday it revealed another 6,000 doses had arrived from the federal Government.

At first, when a person was feeling symptoms of the virus they would be tested locally for the orthopox family of viruses.

If positive, their sample would need to be sent to the CDC for confirmation – a process that could take days.

This meant that even working as fast as possible, case figures in the U.S. were always going to be days behind.

Some of those testing gaps have since been filled, with the CDC announcing in recent days that both Labcorp and the Mayo Clinic had been enlisted in expanding testing capacity.

Still, though, access to monkeypox testing is extremely limited and sparse in a nation of over 330 million people.

‘It’s pretty clear that we need to rapidly scale up the ability to diagnose this now,’ said Dr Jay Varma, a Cornell University public health expert who advised the New York City’s mayor’s office during the COVID-19 pandemic.

Some experts are comparing this shortage of testing to where America was early on in the Covid pandemic.

One significant difference is that the scientific community had no idea what Covid was when it fist emerged, and how to diagnose it was still unclear.

With a virus like monkeypox, which is endemic in some parts of the world and occasionally pops up in the United States, experts believe the same mistakes should not have been repeated again.

‘We clearly identified this as a major mistake that allowed Covid to get its footprint in the U.S. and spread undetected for a month, without any of us knowing… and now we’re just doing the same thing all over again, because that’s the way it’s done,’ Dr Angela Rasmussen, a public health expert at Canada’s University of Saskatchewan told the Times.

The rolling out of vaccines has been spotty as well. American officials are believed to have around 800,000 doses of the two-shot Jynneos vaccine – a figure that may not be nearly enough.

When vaccines have become available, supply has not been able to meet demand. In New York City – the nation’s virus hotspot – walk-in events to receive the jabs often reach maximum demand within minutes of opening.

These failures to properly track and prevent spread of the virus has many experts fearing that the virus will become endemic in the U.S., as it has in parts of West and Central Africa.





Getting Ready for MONKEYPOX to be the NEW PANDEMIC: Have Scientists Been Monkeying Around with the Pox In the So-called NON-EXISTENT UKRAINIAN BIO LABS?

Enquiring minds want to know


Pentagon Quietly Reveals How Many Bio labs They Have in Ukraine and It’s a Lot More Than Their Original Claim of Zero

By JD Rucker

Russia lies a lot. So does the Pentagon. They now have competing lies over the biolabs in Ukraine. This isn’t a question of which side is lying because both are. We just need to know who’s lying more.

The Pentagon is still working hard to counter the Russian narrative that U.S.-funded biolabs in Ukraine are there for peaceful purposes only. This is actually the second change to their original narrative that there were no U.S.-funded biolabs in Ukraine. But in their efforts to cover-up and debunk claims by Russia, they’re talking out of both sides of their mouth.

A press release from the Pentagon even invoked “WMD removal” as a predicate for their ongoing efforts. However, they do not address the fact that they’ve been working on these projects for three decades, nor do they satisfactorily address why they have 46 of them.

According to the release [emphasis added]:

Ukraine has no nuclear, chemical, or biological weapons programs. On March 11 and 18, 2022, United Nations (UN) High Representative for Disarmament Affairs Izumi Nakamitsu similarly stated that the UN is not aware of any biological weapons programs in Ukraine. Those comments were reiterated on May 13, 2022, by the UN Deputy High Representative for Disarmament Affairs. 

oday, the collaborations in Ukraine remain peaceful efforts to improve nuclear and radiological safety and security, disease surveillance, chemical safety and security, and readiness to respond to epidemics and pandemics such as COVID-19.

Ukraine has become a leader in transparencyand in promoting nonproliferation and global health security norms. For example, in December 2021, Ukraine completed a voluntary, external, WHO-led evaluation of its capacity to prevent, detect, and rapidly respond to public health emergencies.

There are several problems with the Pentagon’s claims. On one hand, they say Ukraine has no nuclear, chemical, or biological weapons programs, backing this claim by saying the U.N. is not aware of any. That’s not reassuring when both the Pentagon and U.N. claimed just a few months ago that there were no U.S.-funded biolabs in Ukraine at all.

Even more concerning is that they claim the labs they’re operating in Ukraine have as one of their purposes to improve “readiness to respond to epidemics and pandemics such as COVID-19.” This is problematic because whenever any labs, whether state-funded or private, are engaged in biological weapons research, they always claim the presence of pathogens in their labs is for defensive purposes only. China does it. Russia does it. Apparently, the U.S. is doing it as well.

The fact that they claim Ukraine has become a leader in transparency is a direct insult to our intelligence. Ukraine remains one of the most corrupt and least transparent nations in the world. This is why Joe Biden shuffled his son there to work for Ukrainian energy firm Burisma. What happens in Ukraine, stays in Ukraine.

It would be possible to claim there were a few one-off labs that remained since the fall of the Soviet Union over thirty years ago. Keeping a remnant intact is justifiable for WMD “stragglers.” But buried in the Pentagon’s release was a bombshell that they’ve been hiding for months. They have 46 “peaceful” Ukrainian labs in operation. From one side of their mouth they say Ukraine has no weapons of mass destruction such as nuclear arms or biological agents, and they claim this is due to their efforts disposing them all over the past three decades. Then, out of the other side of their mouth they acknowledge there are 46 U.S.-funded labs in a nation that borders Russia.

The United States has also worked collaboratively to improve Ukraine’s biological safety, security, and disease surveillance for both human and animal health, providing support to 46 peaceful Ukrainian laboratories, health facilities, and disease diagnostic sites over the last two decades. The collaborative programs have focused on improving public health and agricultural safety measures at the nexus of nonproliferation. 

I’ve avoided this topic for the past few months because there simply wasn’t enough information to know who was lying more. That’s the problem when dealing with an argument between the Pentagon and Russia. Both are known to lie regularly. There’s a fine line between spreading the truth and unwittingly aiding either side of the Russia-Pentagon propaganda war. But this admission by the Pentagon lends to the notion that they’re lying more about the biolabs. That’s not to say Russia isn’t lying about them as well. Lies in this case are not mutually exclusive.

I talked more about all this on the latest episode of America First Report. SOURCE

From breitbart.como

W.H.O. Activates Monkeypox Emergency Panel as Case Numbers Soar

Soaring monkeypox case numbers have been cited by the World Health Organization (W.H.O.) as the reason it will reconvene its expert committee to decide whether the outbreak constitutes a global health emergency.

The move comes on the back of an official in New York City reporting a spike in monkeypox cases where incidents more than doubled in the past week. The official states the outbreak in the nation’s largest city accounts for 30 percent of all U.S. cases, as Breitbart News reported.

The U.N. subsidiary health agency is now aware of 9,200 cases in 63 countries at the last update issued Tuesday.

AFP reports monkeypox infections have been slowly building since early May outside the West and Central African countries where the disease has long been endemic.
But a majority advised the W.HO.’s chief Tedros Adhanom Ghebreyesus that the situation, at that point, had not met that threshold.

Now a second meeting will be held on Thursday.

“The emergency committee will provide its views to the W.H.O. director general on whether the event constitutes a PHEIC,” the agency said in a statement.

WARNING: This section of the article from Breitbart may offend people. But I choose to publish it in its entirety

The U.S. Centers for Disease Control and Prevention (CDC) has delivered intimate guidance for those considering sexual activity in an age of monkeypox. The tips come under the published heading Social Gatherings, Safer Sex and Monkeypox.

“If so, it will propose temporary recommendations on how to better prevent and reduce the spread of the disease and manage the global public health response.”

A statement will be issued in the days following the meeting.

Among the cases who reported at least one symptom, 81 percent presented with a widespread rash on the body, 50 percent presented with fever and 41 percent presented with genital rash.

The W.H.O.’s 16-member emergency committee on monkeypox is chaired by Jean-Marie Okwo-Bele from the Democratic Republic of Congo, who is a former director of the W.H.O.’s Vaccines and Immunisation Department.

Most monkeypox infections so far have been observed in – but by no means limited to – men who have sex with men, of young age and chiefly in urban areas, according to the W.H.O. SOURCE